AKT-0XX Inflamation therapy(Akthelia Pharmaceuticals)

N/A

Report date: 2024/01/16 17:48:07

Base Information

Drug NameAKT-0XX Inflamation therapy(Akthelia Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIceland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkthelia Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesAkthelia Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsCrohn Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A